Pharma Focus Asia

Pharma Press Releases

Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.

bioLIVE report forecast bioconjugation expertise and increased productivity in bio over next 5-years

Friday, September 28, 2018

Ahead of the inaugural edition of bioLIVE the bioprocessing and manufacturing event opening October in Madrid CPhI Worldwide announces the bio findings of its annual report which foresees much greater efficiency in biomanufacturing and an increase...

18th Annual Strategic Project & Portfolio Management for Pharma

Friday, September 28, 2018

The th annual marcus evans conference on Project Portfolio Management PPM will look at overall portfolio strategy with the clear understanding that decision making and portfolio prioritization is closely linked to robust evaluation and strong analyti...

Protagonist Therapeutics Announces Fast Track Designation Granted by U.S. FDA to Hepcidin Mimetic PTG-300

Friday, September 28, 2018

Protagonist Therapeutics Inc today announced that the US Food and Drug Administration FDA has granted Fast Track designation to therapeutic candidate PTG for the treatment of chronic anemia due to ineffective erythropoiesis in patients with betathala...

Emerald Health Pharmaceuticals Initiates Phase I Clinical Study on its Oral Drug Candidate Derived from Cannabidiol

Friday, September 28, 2018

Emerald Health Pharmaceuticals Inc EHP a company developing medicines based on cannabinoid science today announced the initiation of enrollment of its Phase I clinical trial of EHP an oral formulation of a patented synthetic new chemical entity NCE d...

Nutriband Inc. Signs Acquisition Agreement of Carmel Biosciences and FDA Approved Prexxartan™

Thursday, September 27, 2018

Nutriband Inc is pleased to announce it has signed the definitive acquisition agreement to acquire Carmel Biosciences Inc The acquisition is expected to be valued at approximately and will be paid in company stock in the amount of restricted common...

I-Mab Biopharma Expands Strategic Collaboration with WuXi Biologics and Licenses WuXiBody™ Platform for Three Bispecific Antibody Programs

Thursday, September 27, 2018

WuXi Biologics a leading global openaccess biologics technology platform company offering endtoend solutions for biologics discovery development and manufacturing and IMab Biopharma IMab a biotech company focusing exclusively on innovative biologics...

NEC Laboratories Europe GmbH, the National Center for Tumor Diseases and Protagen AG collaborate to improve information integration and artificial intelligence for better therapy decisions in

Wednesday, September 26, 2018

Protagen AG the National Center for Tumor Diseases NCT and NEC Laboratories Europe GmbH have today announced a collaboration to improve the in silico prediction of immunotherapy response in malignant melanomaCancer immunotherapy eg by Checkpoint...

Pharmadule Morimatsu wins European design order for a modular F&F facility

Wednesday, September 26, 2018

Pharmadule Morimatsu AB the Swedishbased worldwide turnkey supplier specialist in modular construction facility engineering and process equipment for the pharma and biotech industries has received an order from a highly recognized global Pharmaceutic...

Vetter grants award for novel idea at the Open Innovation Challenge – Injection 2.0

Wednesday, September 26, 2018

Taking part in the Open Innovation Challenge Injection which initially began in June participants consisting of four teams submitted their ideas on how digital trends can be made to be both useful and profitable in the everyday life of its users F...

SiteOne Therapeutics Receives NIH Grant to Support the Development of Novel Therapeutics to Treat Ocular Pain

Wednesday, September 26, 2018

SiteOne Therapeutics a private biopharmaceutical company advancing novel nonopioid pain therapeutics today announced the company has been awarded a million twoyear Phase SBIR grant from the National Eye Institute NEI a member of the US National Ins...